Pharmicell Co., Ltd. (KRX:005690)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,210
-490 (-2.77%)
Last updated: Feb 26, 2026, 11:57 AM KST

Pharmicell Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2013FY 2012FY 2011FY 2010FY 2009
Period Ending
Feb '26 Dec '13 Dec '12 Dec '11 Dec '10 Dec '09
1,062,071164,023213,530370,682173,37575,442
Market Cap Growth
94.93%-23.18%-42.39%113.80%129.81%169.18%
Enterprise Value
-172,343219,632376,638176,42472,037
Last Close Price
17700.003770.555087.2510495.957173.023723.00
PS Ratio
44.354.9119.2236.0524.0210.50
PB Ratio
12.601.992.104.4817.505.47
P/TBV Ratio
21.453.443.276.6117.605.52
EV/Sales Ratio
-5.1619.7736.6324.4410.02
Debt / Equity Ratio
0.140.110.270.181.400.63
Net Debt / Equity Ratio
0.030.080.060.070.520.06
Net Debt / EBITDA Ratio
-0.37-1.49-0.53-0.43-0.51-0.34
Net Debt / FCF Ratio
-0.29-2.00-0.42-0.36-0.57-0.13
Asset Turnover
0.210.280.090.160.270.37
Inventory Turnover
5.055.132.655.224.844.81
Quick Ratio
1.050.680.890.730.704.77
Current Ratio
1.341.091.080.910.855.41
Return on Equity (ROE)
-29.25%-27.93%-19.14%-39.23%-100.35%-39.62%
Return on Assets (ROA)
-4.98%-4.16%-7.50%-14.69%-24.61%-7.89%
Return on Capital Employed (ROCE)
-10.50%-9.10%-13.50%-18.20%-99.10%-11.90%
Earnings Yield
-2.52%-15.67%-8.26%-4.90%-6.84%-5.24%
FCF Yield
-0.74%-1.93%-6.72%-4.54%-5.16%-7.77%
Buyback Yield / Dilution
-7.56%-11.91%-44.48%-1161.86%86.50%8.16%
Updated Aug 29, 2014. Source: S&P Global Market Intelligence. Standard template. Financial Sources.